1.Application Progress of Vitreoscilla Hemoglobin
Ning YUAN ; You-Jia HU ; Chun-Bao ZHU ;
China Biotechnology 2006;0(12):-
Vitreoscilla Hemoglobin(VHb), with the function of increasing the growth of and product yield by a heterologous host, has been widely use in the area of fermentation, environment protection, transgenic animal and plant, recombinant protein expression, etc. Fusion protein of VHb with other enzyme or protein can enhance activity and stability of the enzyme or isolation efficiency of the protein. The reconstitution of VHb will be helpful to obtain ‘novel’ proteins which have better activity.
2.Determination of trans-1,1,1,4,4,4-hexafluoro-2-butene in workplace air by gas chromatography
HU Jia wen CHEN Jia chun YUAN Jing WU Fan RONG Wei feng SHAO Jun li
China Occupational Medicine 2022;49(05):582-
Objective - ,,,,,- - -
To establish a gas chromatographic method for the determination of trans 1 1 1 4 4 4 hexafluoro 2
[ - ()] Methods - ()
butene HFO 1366mzz E in workplace air. HFO 1366mzz E in air was directly collected with aluminum foil
, , ,
composite plastic bag separated by dimethylpolysiloxane capillary column detected by flame ionization detector and
Results - () - 3,
quantified with external standard method. The linear range of HFO 1366mzz E was 6.82 68 200.00 mg/m with the
3,
correlation coefficient of 0.999 9. The detection limit and the lower limit of quantitation were 0.59 and 1.98 mg/m respectively.
- - -
The recovery rate was within 95.45% 103.05%. The relative standard deviation of within batch precision and between batch
- - ,
precision were 2.26% 5.07% and 4.09% 6.82% respectively. The samples can be stored at room temperature for at least seven
Conclusion , ,
days. This method is simple to use with a wide linear range low detection limit high accuracy and precision and
- ()
good sample stability. It can be used for the detection of HFO 1366mzz E in the air of workplace
3.Cloning and Expression of dauW Gene from Daunorubicin-producing Streptomyces coeruleorubidus SIPI-1482
He HU ; Ke SHANG ; You-Jia HU ; Bao-Quan ZHU ; Chun-Bao ZHU ;
China Biotechnology 2006;0(12):-
A novel gene,located between dnrX and drrB in the genome of daunorubicin-producing strain Streptomyces coeruleorubidus SIPI-1482,was cloned and named as dauW.The full sequence of dauW was submitted to GenBank(Accession No.EF523565).Blast result indicated that it showed high homology with dnrW in GenBank.The exact function of dauW is as yet unknown despite the possibility that it might belong to a family of FAD-dependent oxidoreductases on the basis of conserved domain analysis.dauW was cloned into expression plasmids pET-28a(+)and pET-32a(+),respectively,and was successfully expressed in E.coli DE3 after induction with IPTG.The preliminary results of the expression of dauW suggested that it might be involved in the self resistance in Streptomyces coeruleorubidus due to the increased resistance to daunorubicin in the E.coli host.
4.Study on HPLC fingerprint of jinzhen oral solution.
Jun-Hua HU ; Qian-Qian SU ; Ting-Ting LI ; Jia-Chun LI ; Wei XIAO
China Journal of Chinese Materia Medica 2014;39(19):3768-3771
The HPLC fingerprint determination method of Jinzhen oral solution was established to provide a new method for quality control of Jinzhen oral solution. RP-HPLC was used for phenomenex Luna C18 (4.6 mm x 250 mm, 5 μm) chromatographic column, with 0.1% H3 PO4 water solution and acetonitrile as the mobile phase for gradient elution. The detection wavelength was 280 nm. HPLC fingerprint of Jinzhen oral solution was established to identify 17 common peaks in Jinzhen oral solution. The similarity of fingerprints of 10 batches of finished products was more than 0. 90. The established HPLC fingerprint has a better precision, reproducibility and stability, and can be applied in quality control of Jinzhen oral solution.
Chromatography, High Pressure Liquid
;
methods
;
Drugs, Chinese Herbal
;
chemistry
;
Quality Control
5.Neurotoxicity and biomarkers of lead exposure: a review.
Kang-sheng LIU ; Jia-hu HAO ; Yu ZENG ; Fan-chun DAI ; Ping-qing GU
Chinese Medical Sciences Journal 2013;28(3):178-188
Appropriate selection and measurement of lead biomarkers of exposure are critically important for health care management purposes, public health decision making, and primary prevention synthesis. Lead is one of the neurotoxicants that seems to be involved in the etiology of psychologies. Biomarkers are generally classified into three groups: biomarkers of exposure, effect, and susceptibility.The main body compartments that store lead are the blood, soft tissues, and bone; the half-life of lead in these tissues is measured in weeks for blood, months for soft tissues, and years for bone. Within the brain, lead-induced damage in the prefrontal cerebral cortex, hippocampus, and cerebellum can lead to a variety of neurological disorders, such as brain damage, mental retardation, behavioral problems, nerve damage, and possibly Alzheimer's disease, Parkinsons disease, and schizophrenia. This paper presents an overview of biomarkers of lead exposure and discusses the neurotoxic effects of lead with regard to children and adults.
Alzheimer Disease
;
chemically induced
;
metabolism
;
pathology
;
physiopathology
;
psychology
;
Animals
;
Behavior
;
drug effects
;
Biomarkers
;
metabolism
;
Brain
;
metabolism
;
pathology
;
physiopathology
;
Brain Diseases
;
chemically induced
;
pathology
;
physiopathology
;
Environmental Exposure
;
adverse effects
;
Humans
;
Lead
;
pharmacokinetics
;
toxicity
;
Lead Poisoning
;
etiology
;
metabolism
;
pathology
;
physiopathology
;
psychology
;
Neurotoxicity Syndromes
;
etiology
;
metabolism
;
pathology
;
physiopathology
;
psychology
;
Parkinson Disease, Secondary
;
chemically induced
;
metabolism
;
pathology
;
physiopathology
;
psychology
;
Schizophrenia
;
chemically induced
;
metabolism
;
pathology
;
physiopathology
6.Disruption and Compensation of dnmV Gene from Daunorubicin-producing Strain Streptomyces coeruleorubidus SIPI-1482
Ke SHANG ; Qian GONG ; You-Jia HU ; Chun-Bao ZHU ; Bao-Quan ZHU ;
China Biotechnology 2006;0(07):-
TDP-4-ketohexulose reductase, encoded by dnmV, is important in daunorubicin biosynthesis. To obtain a daunorubicin block mutant, double cross-over plasmid pYG817 was constructed by inserting apramycin resistant gene and amplified dnmV together with upstream dnmU into vector pUC18. dnmV was successfully disrupted after transformation of daunorubicin-producing strain SIPI-1482 by pYG817. Daunorubicin was absent from metabolites of the resulting transformant, and its biosynthesis can be reconstituted by introducing dnmV expression plasmid into the disruptant, although the yield is lower than wild-type SIPI-1482, according to HPLC analysis. This mutant can be a good candidate for production of anthracycline such as epi-daunorubicin by introducing exogenous gene into the host.
7.DNA Shuffling of Vitreoscilla Hemoglobin
Ning YUAN ; You-Jia HU ; Chun-Bao ZHU ; Bao-Quan ZHU ;
China Biotechnology 2006;0(11):-
To improve the growth enhancement activity of Vitreoscilla hemoglobin(VHb), Vitreoscilla hemoglobin gene(vgb) was mutated by error-prone PCR and then reconstituted by DNA shuffling. The shuffling library was constructed by inserting the shuffled genes into the downstream of vgb natural promoter and transforming them into E.coli DH5?. Mutated active VHb proteins were first screened in test tubes according to host cell pellets color and then in shake flasks according to host pellets wet weight .One active mutant protein, VHb′042506, was obtained after second screening. It could increased the host wet weight by 31.25% and 58.75% than that of the control which bearing natural VHb under microaerobic and extremely microaerobic conditions, respectively. Sequencing and alignment results showed that 11 nucleotides were mutated, thus resulted in 4 amino acids changes occurred in this mutant protein. CO difference spectrum test also indicated that it had higher specific absorption.
8.Expression and Characterization of Thrombin Inhibitor TTI
Li-Ping XIE ; Ke SHANG ; Chun-Bao ZHU ; Bao-Quan ZHU ; You-Jia HU ;
China Biotechnology 2006;0(10):-
TTI gene coding for Tsetse thrombin inhibitor was modified with E.coli bias codon and expressed in Escherichia coli with high efficiency.Recombinant protein was purified to more than 98% purity.Assay for enzyme activity determination was set up.The result showed that the fusion protein exhibited inhibiting activity for thrombin.Inhibitory rate of purified TTI was 73% when concentration of thrombin and substrate was 10U/ml and 250?mol/L respectively.Inhibition pattern was determined as competitive with Ki at 35?mol/L.
9.A review of time-effect research on acupuncture in experimental rats/mice in the recent 10 years
Hai LU ; Jia-Hui HU ; Li-Sha HAN ; Chun-Hong ZHANG ; Yu WANG
Journal of Acupuncture and Tuina Science 2020;18(4):315-320
Objective: To summarize the influence patterns of related time factors on acupuncture effectiveness in different disease model rats/mice, and to provide reference for acupuncture clinical practice. Methods: Retrieved the relevant literatures on time-effect experimental studies of acupuncture in rats/mice in the recent 10 years. The correlations between the key time factors (such as different intervention timings of acupuncture, acupuncture moments, operation durations, needle-retaining times, intervals and treatment courses) and the acupuncture effect were analyzed and summarized. Results: From the mainstream perspective of quantification, the earlier the acupuncture intervention, the better. The proper time to implement acupuncture varied depending on disease models and points. The best operation time varied widely between different diseases. The most frequently needle-retaining time was 20-30 min. The frequency of acupuncture was usually 1 time/day; the length of the treatment course was determined according to practitioners' experience. Conclusion: Throughout the time-effect studies of acupuncture intervention in experimental rats/mice, conclusions are inconsistent, especially the lack of quantitative research on acupuncture operation time, acupuncture frequency, acupuncture treatment duration, and optimal stimulation amount. Future research should explore and determine the best time-quantity parameters that affect the effectiveness of acupuncture intervention, which is the key and goal of the acupuncture time-effect research. Independent intervention-time experiments throughout the entire course of a single disease (dominant disease) need to be done to guide clinical and disciplinary development.
10.Research progress of drug toxicity mechanism based on the gut microbiota
Jia-chun HU ; Meng-liang YE ; Jian-ye SONG ; Jian-dong JIANG ; Yan WANG
Acta Pharmaceutica Sinica 2023;58(12):3549-3556
The exploration of drug toxicity and mechanisms is a vital component in ensuring the safe use of drugs in clinical practice, as this topic has attracted widespread concern. The intestinal flora holds great significance for drug metabolism, efficacy and mechanism, and is an instrumental metabolic organ that facilitates material information transfer and biotransformation. However, an increasing number of studies have shown that intestinal bacteria are closely related to the toxicity of specific drugs. On the one hand, drugs are transformed into toxic metabolites under the influence of intestinal bacteria, thus inducing direct drug toxicity. On the other hand, the composition and function of the intestinal flora are altered under drug influence, resulting in disruption of endogenous metabolic pathways. Consequently, this disruption compromises the intestinal barrier and affects other organs, leading to indirect drug toxicity. This review meticulously compiles recent examples of drug toxicity attributed to intestinal bacteria, explores in depth the contention that metabolic enzymes of gut microbiota may be of great influence on oral drug toxicity, and outlines prospective avenues for future research on gut microbiota and drug toxicity and mechanisms. This not only provides novel perspectives for the judicious clinical utilization of drugs but also offers insights for the safety assessment of innovative pharmaceuticals.